The Board of Directors includes some of the country’s most distinguished biomedical research scientists:

Keith R. Yamamoto (Chair)
University of California, San Francisco

Huda Akil (SFN)
University of Michigan

Sue Biggins (at-large)
Fred Hutchinson Cancer Research Center
Howard Hughes Medical Institute

Martin Chalfie (at-large)
Columbia University
Biological Sciences

Anne Claiborne (CZI)
Chan Zuckerberg Initiative

Hollis Cline (SFN)
The Scripps Research Institute
Department of Neuroscience

Mark C. Fishman, (at-large)
Harvard University
Harvard Stem Cell Institute

Carol Greider (ASCB)
Johns Hopkins School of Medicine
Daniel Nathans Professor and Director
Department of Molecular Biology and Genetics

James Haber (GSA)
Brandeis University

Robert Horvitz (at-large)
Massachusetts Institute of Technology
Howard Hughes Medical Institute

Steven E. Hyman (at-large)
Harvard University
Broad Institute of MIT and Harvard

Judith Kimble (at-large)
Vilas Professor of Biochemistry
Departments of Biochemistry and Medical Genetics
University of Wisconsin-Madison
Howard Hughes Medical Investigator

Boyana Konforti (HHMI)
Howard Hughes Medical Institute

Connie M. Lee (ASCB)
Associate Dean for Basic Science
Biological Sciences Division
The University of Chicago

Richard Lifton (at-large)
The Rockefeller University
Howard Hughes Medical Institute

Bill Martin (at-Large)
Chief Scientific Officer and Head of R&D
BlackThorn Therapeutics, Inc

Elizabeth McNally (at-large)
Northwestern University Feinberg School of Medicine

Richard M. Myers (HudsonAlpha)
HudsonAlpha Institute for Biotechnology

Erin O’Shea (HHMI)
Howard Hughes Medical Institute

Vishal Patel (NIBR)
Novartis Institutes for BioMedical Research

Thomas Pollard (at-large)
Yale University
Department of Molecular/Cellular/ Dev Biology

James Sabry (Genentech)
Genentech, Inc

Bodo Stern (HHMI)
Howard Hughes Medical Institute

Tania Simoncelli (CZI)
Chan Zuckerberg Initiative

Shirley Tilghman (at-large)
Princeton University
President of the University, Emeritus
Professor of Molecular Biology and Public Affairs